November 14, 2023
Breakthrough T1D Moves the Type 1 Diabetes Community “Forward” in Honor of World Diabetes Day and National Diabetes Awareness Month
November 8, 2023
Breakthrough T1D Comments on New Disease-Modifying Therapy Research Published in Lancet
November 3, 2023
Breakthrough T1D’s Statement During Today’s Medicare Drug Price Negotiation Program Patient-Focused Listening Session for Insulin Products, Fiasp and Novolog
October 25, 2023
Grant given to the University of Dundee for research in patients with type 1 diabetes with heart failure
October 18, 2023
Breakthrough T1D Encouraged by Results of PROTECT Clinical Trial
October 17, 2023
Breakthrough T1D Chief Scientific Officer Dr. Sanjoy Dutta to Present at ISPAD on Global Type 1 Diabetes Screening
October 16, 2023
A Message to Our Community
October 13, 2023
Our UK Affiliate: Breakthrough T1D commits £1.3 million to investigate medication with the potential to delay kidney complications
October 4, 2023
Use of antiviral medication shown to preserve insulin production in children with new-onset type 1 diabetes
October 2, 2023
Ontario life sciences startup, Allarta, receives award from Breakthrough T1D to advance its work in creating a functional cure for type 1 diabetes
